Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Donna Zhang
Mechanism of Progestin Resistance in Endometrial Precancer/Cancer Through Nrf2-Akr1c1 Pathway
Oncotarget
Oncology
Related publications
Progestin Therapy for Endometrial Cancer: The Potential of Fourth-Generation Progestin (Review)
International Journal of Oncology
Cancer Research
Oncology
Biomarkers Needed to Predict Progestin Response in Endometrial Cancer
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance
Frontiers in Medicine
Medicine
P62 Suppressed VK3-induced Oxidative Damage Through Keap1/Nrf2 Pathway in Human Ovarian Cancer Cells
Journal of Cancer
Oncology
Hsa_circ_0079662 Induces the Resistance Mechanism of the Chemotherapy Drug Oxaliplatin Through the TNF-α Pathway in Human Colon Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A Review of the Literature
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer
Annual Review of Cancer Biology
IDH1 R132H Mutation Regulates Glioma Chemosensitivity Through Nrf2 Pathway
Oncotarget
Oncology
Treatment Efficiency of Comprehensive Hysteroscopic Evaluation and Lesion Resection Combined With Progestin Therapy in Young Women With Endometrial Atypical Hyperplasia and Endometrial Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics